CF
CABA icon

Cantor Fitzgerald’s Cabaletta Bio CABA Stock Holding History

Cantor Fitzgerald’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.49M Buy
800,001
+35,001
+5% +$115K 0.03% 174
2026
Q1 		$2.06M Buy
+765,000
New +$2.12M 0.03% 150
2025
Q3 		– Sell
-532,500
Closed -$809K – 399
2025
Q2 		$809K Sell
532,500
-952,085
-64% -$1.48M 0.01% 178
2025
Q1 		$2.06M Buy
1,484,585
+1,384,585
+1,385% +$2.95M 0.04% 84
2024
Q4 		$224K Buy
+100,000
New +$351K ﹤0.01% 174

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Cantor Fitzgerald's CABA Position: Q2 2026 in Review

Cantor Fitzgerald increased its Cabaletta Bio (CABA) stake by 4.6% in Q2 2026, buying an estimated $115K and bringing the position to 800,001 shares worth $2.49M. The position accounts for 0.03% of the portfolio, ranked #174.

Cantor Fitzgerald first reported a position in CABA in Q4 2024 and has held it in 5 quarters since. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Cantor Fitzgerald held 800,001 shares of Cabaletta Bio worth $2.49M as of Q2 2026.
  • Cantor Fitzgerald bought 35,001 Cabaletta Bio shares in Q2 2026, an estimated $115K.
  • Cabaletta Bio made up 0.03% of Cantor Fitzgerald's portfolio in Q2 2026, its #174 holding.
  • Cantor Fitzgerald first reported a position in Cabaletta Bio in Q4 2024 and has held it in 5 quarters since.
  • 140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Cantor Fitzgerald's 13F filing for Q2 2026, filed 14 Aug 2026.